NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
Show detailsBibliographic details: Schreiber J U, Lysakowski C, Fuchs-Buder T, Tramer M R. Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials. Anesthesiology 2005; 103(4): 877-884. [PubMed: 16192781]
Abstract
Fifty-two randomized trials (5,318 patients) were included in this meta-analysis. In controls, the incidence of fasciculation was 95%, and the incidence of myalgia at 24 h was 50%. Nondepolarizing muscle relaxants, lidocaine, or magnesium prevented fasciculation (number needed to treat, 1.2-2.5). Best prevention of myalgia was with nonsteroidal antiinflammatory drugs (number needed to treat, 2.5) and with rocuronium or lidocaine (number needed to treat, 3). There was a dose-dependent risk of blurred vision, diplopia, voice disorders, and difficulty in breathing and swallowing (number needed to harm, < 3.5) with muscle relaxants. There was evidence of less myalgia with 1.5 mg/kg succinylcholine (compared with 1 mg/kg). Opioids had no impact. Succinylcholine-induced fasciculation may best be prevented with muscle relaxants, lidocaine, or magnesium. Myalgia may best be prevented with muscle relaxants, lidocaine, or nonsteroidal antiinflammatory drugs. The risk of potentially serious adverse events with muscle relaxants is not negligible. Data that allow for a risk-benefit assessment are lacking for other drugs.
- Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis...Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials - Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews
- FUT2 [Camelus ferus]FUT2 [Camelus ferus]Gene ID:102522076Gene
- ATP6V0A2 [Sturnus vulgaris]ATP6V0A2 [Sturnus vulgaris]Gene ID:106852450Gene
- LOC109931378 [Rhincodon typus]LOC109931378 [Rhincodon typus]Gene ID:109931378Gene
- PREDICTED: Homo sapiens EMAP like 5 (EML5), transcript variant X14, mRNAPREDICTED: Homo sapiens EMAP like 5 (EML5), transcript variant X14, mRNAgi|1370464666|ref|XM_011536534.3|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...